New Key Statistics Module, Z-Score and F-Score
NAS:SLN Key Ratios
| Market Cap $ M | 1,073.18 |
| Enterprise Value $ M | 1,005.13 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 38.46 |
| Price/Sales | 24.31 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 31.00 |
| EPS (TTM) $ | -1.46 |
| Beneish M-Score | -2.42 |
| 10-y EBITDA Growth Rate % | -11.40 |
| 5-y EBITDA Growth Rate % | -10.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -12.99 |
| EV-to-EBITDA | -13.12 |
| PEG | -- |
| Shares Outstanding M | 46.66 |
| Net Margin (%) | -171.78 |
| Operating Margin % | -196.58 |
| Pre-tax Margin (%) | -199.51 |
| Quick Ratio | 4.56 |
| Current Ratio | 4.56 |
| ROA % (ttm) | -44.79 |
| ROE % (ttm) | -247.96 |
| ROIC % (ttm) | -168.77 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.89 |
SLN Number of Guru Trades
SLN Volume of Guru Trades
Gurus Latest Trades with NAS:SLN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SLN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Silence Therapeutics PLC Insider Transactions
No Available Data
News about NAS:SLN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers